Eli Lilly says psoriasis drug meets goal in study - BusinessWeek

Eli Lilly says psoriasis drug meets content in study BusinessWeek Eli Lilly and Co. aforementioned Wednesday its experimental disease of the skin drug met its goals in a mid-stage clinical trial. Lilly said the drug, called ixekizumab, was more effective than type A placebo at treating average to severe plaque disease of the skin . Biologic Treatments Gregorian calendar month Ease Psoriasis WebMD IL-17 New Target in disease of the skin MedPage Today Two enquiry Drugs Could Improve disease of the skin Treatment U.S. News & World Report MarketWatch (press release) all 46 tidings articles » Link To Article